The human POLG gene encodes the catalytic subunit of mitochondrial DNA polymerase γ, pol γ. Mutations in pol γ are associated with a spectrum of disease phenotypes including autosomal dominant and recessive forms of progressive external ophthalmoplegia, spino-cerebellar ataxia and epilepsy, and Alpers-Huttenlocher hepatocerebral poliodystrophy. Multiple deletions, or depletion of mtDNA in affected tissues are the molecular hallmarks of pol γ mutations. To shed light on the pathogenic mechanisms leading to these phenotypes, we introduced in MIP1, the yeast homologue of POLG, two mutations equivalent to the human Y955C and G268A mutations, which are associated with dominant and recessive PEO respectively. Both mutations induced the generation of petite colonies, carrying either rearranged (ρ-) or no (ρ°) mtDNA. Mutations in genes that control the mitochondrial supply of deoxynucleotides (dNTP) affect the mtDNA integrity in both humans and yeast. To test as whether the manipulation of the dNTP pool can modify the effects of pol γ mutations in yeast, we overexpressed a dNTP checkpoint enzyme, ribonucleotide reductase, RNR1, or deleted its inhibitor, SML1. In both mutant strains the petite mutability was dramatically reduced.
INTRODUCTION
Different mutations in POLG, the gene encoding the catalytic subunit of the mitochondrial DNA polymerase (polymerase gamma, pol γ) (1) are associated with a spectrum of human mitochondrial disorders, including autosomal dominant (ad) and autosomal recessive (ar) progressive external ophthalmoplegia (PEO), juvenile spino-cerebellar ataxia and epilepsy (SCAE) (2) and infantile hepatopatic poliodystrophy, or Alpers-Huttenlocher syndrome (AHS) (3) . Adult-onset adPEO and arPEO syndromes are characterized by the accumulation of multiple mtDNA deletions in affected tissues (4) , while the most severe syndrome, AHS, shows marked reduction in the mtDNA copy number in liver (5) and, possibly, brain. Beside mutations in POLG, adPEO can also be caused by heterozygous mutations in ANT1, encoding the ADP/ATP translocator (6) , and TWINKLE, encoding a mitochondrial helicase (7) . ANT1 and POLG genes, but not TWINKLE, are highly conserved from humans to the facultative budding yeast Saccharomyces cerevisiae: the yeast AAC2 gene corresponds to ANT1 (8) , while MIP1 corresponds to POLG (9) . This makes it possible to introduce and study in AAC2 and MIP1 the mutations that are equivalent to those affecting mtDNA stability in humans (10, 11, 12) .
Human pol γ is composed of a 140 kDa catalytic subunit A and a 55 kDa accessory subunit B, which increases the processivity of mtDNA synthesis. Pol γA comprises a polymerase domain and an exonuclease proofreading domain, separated by a linker region of 482 amino acids. Over sixty PEO-associated mutations have been found in POLG (13, 14) . Most of the dominant POLG mutations are in the polymerase domain, while most of the recessive mutations are in the exonuclease or in the spacer domains. Only one mutation has been found in pol γΒ (14) .
In the present work, we introduced in MIP1 two mutations that are equivalent to two pathogenic mutations in pol γΑ, the Y955C and the G268A. The first mutation is associated with adPEO (1), while the second is associated with arPEO (15) . We demonstrated that the equivalent yeast mutations behave as dominant and recessive traits respectively, and, by inducing severe 
RESULTS

Effect of MIP1 alleles equivalent to PEO-associated hPOLG mutants on oxidative growth phenotype
Phenotypic analysis showed that the haploid mip1 Y757C mutant strain (Δmip1// mip1 Y757C ) was unable to grow on 2% ethanol, indicating absence of respiration. As exemplified by the experiment shown in Figure 1 , the spectrum profile of mitochondria isolated from this strain consistently lacked of the peaks specific to cytochromes b and aa3, which are part of the mtDNA-dependent complexes III and IV of the respiratory chain, while the peak specific to cytochrome c, a nucleus-encoded protein, was normal. Contrariwise, the haploid mip1 G224A mutant strain (Δmip1// mip1
G224A
) was able to grow on ethanol, displayed a normal cytochrome profile ( Figure 1 ) and retained a normal respiratory activity (data not shown 
) both failed to show a significant growth defect; the cytochrome profile and respiration were normal in both strains.
Determination of petite frequency and evaluation of the nature of the petite mutations
In humans, both G268A and Y955C mutations induce the accumulation of multiple deletions of mtDNA. In S. cerevisiae, deletions of mtDNA are known as petite mutations. Conditions that increase mtDNA mutability also increase the frequency of petites (20) . In order to evaluate whether an effect similar to that observed in humans was produced by the equivalent mutations in yeast, we measured the frequency of petite mutants in haploid Δmip1strains carrying either the mip1 G224A or the mip1 Y757C mutant alleles. The results reported in Figure 2 . This was consistently confirmed by Southern-blot analysis, as exemplified in Figure 3 (see also Methods). clones was able to do so, again indicating that the Y757C mutation induces the loss of mtDNA (Table 3) .
Determination of mtDNA point mutations
We next analysed whether our mip1 mutations increased the mtDNA point mutagenesis, as demonstrated by an increase in the frequency of erythromycin-resistant (Ery R ) mutants. Resistance to the drug erythromycin in yeast is acquired through specific point mutations in the mtDNAencoded rRNA genes and therefore is a convenient, direct measurement of mtDNA point mutagenesis in vivo (21) . Using this assay, we measured mtDNA mutation frequencies in the haploid strain Δmip1//mip1 G224A and in the diploid strains MIP1/Δmip1//mip1 G224A and
. Both mip1 G224A in haploid, and mip1 Y757C in diploid conditions showed a 10-fold and a 20-fold increase respectively in mtDNA point mutagenesis, compared to that observed in the wild-type strain. However, the MIP1/mip1 G224A heterozygous diploid strain failed to show any increase of Ery R mutant frequency (Table 4) , again indicating that this mutation behaves as a recessive trait also for this phenotype.
The effect of increasing dNTP pool on mitochondrial mutability
We next tested whether an increase in the level of the dNTP pool could rescue the mitochondrial mutability observed in the presence of the two pathological mip1 mutations. The increase of the dNTP pool was obtained either by over-expressing the RNR1 gene, which encodes 8 the large subunit of the ribonucleotide reductase (22) or by deleting the SML1 gene, which encodes an inhibitor of the latter activity (18) .
We transformed haploid and diploid strains harbouring the mip1 G224A or the mip1 Y757C alleles with a multicopy plasmid carrying the RNR1 gene (plasmid pWJ841). We also constructed a haploid Δsml1, Δmip1 strain and a diploid Δsml1/Δsml1 MIP1/Δmip1 strain, which were transformed with either one of three different plasmids: the first plasmid carried the wt MIP1 allele, the second the mip1 G224A allele, and the third the mip1 Y757C allele. The results reported in Figure 4 indicate that both conditions caused dramatic decreases of the petite frequencies in the mutant strains. The petite mutability was reduced approximately to the same extent, suggesting that the protective effect on mtDNA is likely due to the increase of the dNTP pool and not to an unrelated effect of the RNR1 over-expression or of the SML1 deletion.
Decreased petite mutability was associated with decreased ρ 0 frequency (Table 3 ). In the presence of RNR1 over-expression the proportion of haploid Δmip1//MIP1 ρ 0 clones was reduced from 46% to 33% and in the presence of the SML1 deletion was reduced to 28%. Similar results were obtained in the haploid Δmip1//mip1 G224A strain. In the heteroallelic strain MIP1//mip1 Y757C resulted in a reduction of ρ 0 clones from 51% to 35% in the presence of over-expressed RNR1 and to 29% in the presence of Δsml1, whereas no reduction was observed in the MIP1//MIP1 homoallelic strain. The 4-5 fold decrease of petite mutability and the 7-10 fold decrease of ρ 0 frequency suggest that the increase of the dNTP pool contributed to maintain mtDNA integrity and stability.
Since the effects obtained by RNR1 over-expression were similar to those obtained with SML1 deletion, we evaluated the effect on mtDNA point mutability only in the Δsml1 background. The number of Ery R mutants was unchanged in the presence of the mip1 G224A mutation, but decreased by approximately two fold in the presence of the mip1 Y757C mutation (Table 4) .
Role of ROS in mtDNA mutability
Increased production of ROS is associated with an increase in the accumulation of mtDNA rearrangements (23, 24) . To address this issue in our system, we analysed the effect of the ROS scavenger dihydrolipoic acid on the petite mutability of the heterozygous MIP1/Δmip1 diploid strain carrying the mip1 Y757C allele, as well as of the Δmip1 haploid strain carrying the mip1
G224A
allele. Exposure to dihydrolipoic acid decreased significantly the petite mutability in both cases by a factor of six to eight. A clear, albeit less prominent, effect was also observed in the mip1 and MIP1/mip1 strains carrying the wild type MIP1 allele ( Figure 5 ).
DISCUSSION
The human Y955C pol γ mutation is located in the polymerase domain. Its fidelity is 42-fold decreased in an exonuclease-deficient background and 2-fold decreased in an exonucleaseproficient background (25) ; its polymerase activity is 3,000-fold decreased (26) . The yeast mutation mip1 Y757C , corresponding to Y955C, behaved like the mip1 null mutation when introduced into a Δmip1 haploid strain. It induced a dramatic loss of mitochondrial DNA, as shown by the production of 100% petite mutants that were all ρ 0 , that is, mtDNA-less cells. In a MIP1/mip1 heterozygous diploid strain, the mip1 Y757C mutation caused a 20-fold increase in petite mutability compared to the MIP1 wt allele and a four-fold increase compared to the mip1 null allele. The mip1 Y757C mutation caused also an increase of point mutability of mtDNA, leading to a ten-fold increase of ERY R mutations compared to the MIP1 wt allele and a three-fold increase compared to the Δmip1 null allele. These results indicate that the mip1 Y757C behaves as a dominant allele, since its presence is more deleterious to mtDNA than the absence of the MIP1 gene itself. This behaviour mimics exactly what is observed in humans.
The human G268A is a missense mutation in the proofreading exonuclease domain of pol γA. In homozygous conditions, the human G268A mutation causes the accumulation of both mtDNA deletions and point mutations (27) . We observed reduced fidelity of the homologous mutation also in yeast, where the equivalent mip1 G224A allele was associated with a 2.5-fold increase in the frequency of petite clones and a 10-fold increase in the point mutability of mtDNA.
Therefore, the phenotype is recessive in yeast as it is in humans.
The recessive phenotype is formally indicative of a complementation exerted by the wildtype allele and is possibly due to the ability of the wild-type MIP1 polymerase to proofread errors introduced by the mutant polymerase.
Mutations in genes that control the mitochondrial supply of deoxynucleotides (dNTP) affect the mtDNA integrity in both humans (28) and yeast (29) .
The level of dNTP pools is under an evolutionary conserved surveillance system that maintains genomic stability. One important checkpoint of this control system is the ribonucleotide reductase (RNR1). In yeast, mutations in RNR1 increase petite mutations (30) . In both yeast and humans, the transcription of RNR1 is induced after DNA damage. In addition, the yeast mtDNAdamage checkpoint proteins also regulate the RNR1 inhibitor Sml1p. After DNA damage or at S phase, the MEC1 and RAD53 gene products control the phosphorylation and the subsequent degradation of the Sml1 protein (31) . This control contributes to increase the synthesis of dNTPs, necessary for DNA replication and repair. Overexpression of RNR1 (32) or deletion of SML1 (18), both are able to rescue the petite-inducing phenotype of a specific point mutation in yeast pol γ
Here we show that either RNR1 overexpression or SML1 deletion, two conditions that increase the dNTP pools of the cell, including the mitochondrial pool (19) , induced a 4-8 fold reduction in the production of petite colonies of our recombinant mutant strains. However, neither RNR1 overexpression nor SML1 deletion decreased the frequency of ERY R clones, which is an index of the propensity of mtDNA to accumulate point mutations. This result is similar to previous data (33) and indicates that induction of large-scale rearrangements, rather than increased point mutagenesis, is responsible for the petite mutability induced by the two mip mutations considered in our work. The human Y955C mutation displays a 45-fold reduction in affinity for the incoming nucleotide (25) . Reduced affinity could determine a stalling on homopolymeric runs due to frequent reiteration of a single nucleotide. This could result in local depletion of that nucleotide and make it difficult for a defective polymerase to incorporate the subsequent nucleotide (34) . By preventing pol γ stalling, an increase of the dNTP pool could decrease the generation of mtDNA rearrangements, and thereby reduce the number of petite clones. However the increase of the dNTP pool could also induce the rescue of petites by improving the efficiency of mtDNA repair, especially in the presence of the D268A mutation, which is an error-prone mutation, being contained in the proofreading domain of pol γA. The existence of mtDNA repair is supported by the recent demonstration that mitochondria share several repair systems with the nucleus, in both yeast (35) and humans (36) .
MtDNA is attached to the mitochondrial inner membrane in close proximity to the respiratory chain. Mitochondrial respiration is a major source of ROS, which makes mtDNA vulnerable to oxidative damage (23) . The latter effect can lead to production of more ROS by impairing the electron transport chain (37) , which can in turn determine further mtDNA damage (38, 39) .
To evaluate whether the mitochondrial mutability consequent to POLG mutations could result from ROS damage on mtDNA, we analysed the effect of a ROS scavenger, dihydrolipoic acid.
Exposure to dihydrolipoic acid caused a six-fold decrease in the petite mutability of the heterozygous MIP1/mip1 diploid carrying the mip1 Y757C dominant allele and of the Δmip1 haploid strain carrying the mip1 G224A recessive allele. However, we could not establish whether the polymerase mutations increase the amount of ROS or whether they make the mtDNA more sensitive to ROS.
We have previously reported that the presence of ROS scavengers reduced significantly the consequences of a mutation equivalent to an arPEO mutation in the human ANT1 gene (11).
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Likewise, the data presented in this paper ushers in the development of a rational anti-ROS strategy for patients with pol γA mutations. 
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MATERIALS AND METHODS
Yeast strains and media.
Yeast strains are listed in Table 1 . YP medium contained 1% Bacto-yeast extract and 2%
Bacto-peptone (Difco). Minimal medium (YNB) contained 7 g/l Yeast Nitrogen Base without amino acids (Difco) supplemented with appropriate amino acids and bases for auxotrophy. Various carbon sources were added at the indicated concentrations. N1 medium contained 1% peptone, 1%
yeast extract, 2% ethanol in 50 mM phosphate buffer at pH 6.3, supplemented with 4g/lt erythromycin (SIGMA).
Construction of yeast strains carrying mip1 mutations.
S. cerevisiae strain W303-1B (40) was used for the construction of a null Δmip1 mutant by one step gene disruption using KanMX expression cassette (41) . MIP1 ORF was completely deleted and substituted by the Kan r marker, whose correct target of at MIP1 locus was verified by PCR.
Oligonucleotides used for MIP1 disruption and verification are listened in Table 1 . Δmip1 mutant strain (strain OF1), ρ 0 , was then crossed with the isogenic strain W303-1A (40) The list of base changes, and corresponding modified primers used to generate mutated vectors, is reported in Table 2 . In order to maximize the expression of these variants, the preferred yeast codons (42) were used in the oligonucleotide sequences used for mutagenesis: GCT for Alanine and TGT for Cysteine. Mutagenized inserts for each different construct were sequenceverified on both strands. The sequences of the oligonucleotide primers used for cloning and sequencing MIP1 are also listed in Table 1 .
Plasmids
MIP1 gene and mutant alleles were cloned in both the centromeric vectors pFL38 and pFL39 (43) at SacI and SalI sites. These vectors carry URA3 and TRP1 markers respectively. RNR1 gene, cloned in the multicopy vector pRS425 (plasmid pWJ841), was kindly obtained from Rodney Rothstein.
Mitochondrial DNA mutation frequency
Analysis of petite frequencies.
Diploid and haploid strains transformed with wt or mutated mip1 alleles were pregrown overnight in YNB medium supplemented with 2% ethanol and then inoculated in the same medium These results indicate that the absence of mit -complementation is a good indicator of a ρ
Erythromycin resistance assays.
Fifteen independent colonies from each strain were inoculated in separate 10-ml cultures of YNB + glucose and allowed to reach the stationary phase. After 24 hours, a small sample was removed to determine the total number of respiration-competent cells by plating onto YP supplemented with 2% ethanol. The remainder of each culture was plated onto solid N1 medium containing 4 mg/ml erythromycin (SIGMA) and grown at 28°C for 8 days until drug-resistant colonies formed. The experiment was carried out in duplicate. The mutation frequency was calculated as number of erythromycin-resistant colonies/total number of colonies.
Miscellaneous
Transformation of yeast strain was obtained by the lithium chloride method (48) . Restriction enzyme digestions, E. coli transformation and plasmid extractions, were performed using standard methods (47) . Cytochrome spectra and respiration were determined as described previously (10) . Δmip1//mip1 The frequency of erythromycin resistant mutants was calculated as number of erythromycinresistant colonies/total number of colonies, as described in Materials and Methods.
